6 Seeking Alpha authors also rated the stock, and their ratings often outperform those of Wall Street analysts. Here are their ratings on VRTX What is Vertex Pharmaceuticals Incorporated's stock price today? Vertex Pharmaceuticals Incorporated is currently listed on NASDAQ under VRTX. One share of ...
Vertex Pharmaceuticals Company Info Vertex is in the business of discovering, developing, and commercializing small-molecule drugs for the treatment of serious genetic diseases including cystic fibrosis. News & Analysis The Fool has written over 1,100 articles on Vertex Pharmaceuticals. Featured Article ...
Current Price ▲455.310 USD 7 Days Forecast Get It Now! 1-Year Forecast* ▲501.996 USD 5-Year Forecast* ▲648.639 USD Historical index on US Stock Market :B+"Should I invest inVertex Pharmaceuticalsstock?" "Should I trade "VRTX" stock today?"According to our live Forecast System,Vertex Ph...
Get Vertex Pharmaceuticals Inc (VRTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Stay up to date with the latest Vertex Pharmaceuticals Incorporated stock price movements on Seeking Alpha's interactive chart. View comprehensive price data and historical prices on VRTX here.
4月12日,纳斯达克上市的生物制药巨头Vertex Pharmaceuticals宣布,计划以每股65美元,总计约49亿美元的价格收购同为美股上市的Alpine公司。该消息一出,Alpine股价当日大幅上涨36.9%,收于64.4美元/股,而Vertex股价亦攀升至400美元/股以上。 此次并购事件不仅在国际市场引发关注,还引起了国内药企巨头的高度兴趣。国内药企已经开...
Today: $PFE, $VRTX, $PLAB, and Bowl Games PFEVRTXPLAB STOCKS Nov 4, 2023 1:25 PM EDT Goldman Sachs is bullish on these 25 stocks (Boeing among them) It’s hard to tell whether the recent stock rally signals sustained gains or the July 31-Oct. 27 decline will resume. BASPGS ...
Pharmaceuticals in the past 3 months VRTX Stock 12 Month Forecast $470.89 ▼(-4.07% Downside) Based on 22 Wall Street analysts offering 12 month price targets for Vertex Pharmaceuticals in the last 3 months. The average price target is $470.89 with a high forecast of $555.00 and a low ...
Industry:Pharmaceuticals CEO:Reshma Kewalramani Website:https://www.vrtx.com/ Ticker:VRTX Company type:Public Revenues ($M):$9,869 Profits ($M):$3,620 Market value ($M):$107,975 Number of employees:5,236 Market value as of March 28, 2024.Vertex Pharmaceuticals stock chartVertex...
The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $376.55, reflecting a +1.95% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily gain of 1.89%. At the sam